Test provides results in about 15 minutes and ‘will be simple, even for people who have never tested themselves’
THURSDAY, April 1, 2021 (HealthDay News) — An over-the-counter rapid COVID-19 test made by Abbott Laboratories has been approved by the U.S. Food and Drug Administration, the company says.
It said that its BinaxNOW test was granted emergency use authorization by the FDA for nonprescription use at home, The Washington Post reported. “This new indication allows individuals with or without symptoms to have access to this test without a prescription,” Abbott said in a statement.
The test provides results in about 15 minutes and “will be simple, even for people who have never tested themselves,” according to the company, The Post reported.
Abbott said it expects to begin shipping the tests to major food and drug retailers in the coming weeks and that they may also be available online. The price to consumers is not known, but a company spokeswoman told Reuters that Abbott plans to sell them to retailers for less than $10 each, The Post reported.
The new test could significantly increase Americans’ access to COVID-19 testing.
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis 
U.S. Adults May Not Understand Their Risk for Vascular Disease 
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators 
Addition of CAC to PREVENT-ASCVD Equations May Improve Predictive Utility in Certain Patients 
.jpg)